Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.

about

Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.

Item

http://www.wikidata.org/entity/Q50089332

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.

@en

Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.

@nl

type

Item

label

Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.

@en

Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.

@nl

prefLabel

Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.

@en

Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.

@nl

P1476

Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.

@en

P2093

José Luís Passos Coelho

http://www.w3.org/2001/XMLSchema#string

José Vale

http://www.w3.org/2001/XMLSchema#string

Mafalda Casa-Nova

http://www.w3.org/2001/XMLSchema#string

Maria João Baptista

http://www.w3.org/2001/XMLSchema#string

Teresa Mesquita

http://www.w3.org/2001/XMLSchema#string

P2860

Subacute reversible toxic encephalopathy related to treatment with capecitabine: a case report with literature review and discussion of pathophysiology.

A case of oxaliplatin-related posterior reversible encephalopathy syndrome.

Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion.

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report.

Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review.

FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs.

Cerebellar ataxia with weekly 5-fluorouracil administration.

Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers

Capecitabine-induced cerebellar toxicity in a patient with metastatic colorectal cancer.

P304

497-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155217739686

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francisco Araújo

João Godinho

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29121830

http://www.w3.org/2001/XMLSchema#string